Conversion to Aflibercept for Diabetic Macular Edema Unresponsive To Bevacizumab in Chicago Cook County Health System

被引：0
|
作者：
Cunningham, Christy [1 ]
Sahni, Sakshi [2 ]
Farahani, Mina [1 ]
Thomas, Catherine [2 ]
Anderson-Nelson, Susan [1 ]
Raiji, Veena [1 ,3 ]
Skondra, Dimitra [1 ,4 ]
机构：
[1] J Stroger Cook Cty Hosp, Chicago, IL USA
[2] Rosalind Franklin Univ Med & Sci, N Chicago, IL USA
[3] Loyola Univ, Ophthalmol, Maywood, IL 60153 USA
[4] Northwestern, Feinberg Sch Med, Chicago, IL USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2077
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [1] Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab or bevacizumab
    Lim, Laurence S.
    Ng, Wei Yan
    Mathur, Ranjana
    Wong, Doric
    Wong, Edmund Y. M.
    Yeo, Ian
    Cheung, Chui Ming Gemmy
    Lee, Shu Yen
    Wong, Tien Yin
    Papakostas, Thanos D.
    Kim, Leo A.
    CLINICAL OPHTHALMOLOGY, 2015, 9 : 1715 - 1718
  • [2] Conversion to aflibercept for diabetic macular edema unresponsive to ranibizumab and/or intravitreal dexamethasone implant
    Herbaut, Antoine
    Knafo, Lise Qu
    Auregan, Audrey Giocanti
    Fajnkuchen, Franck
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [3] Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Wells, John A.
    Glassman, Adam R.
    Ayala, Allison R.
    Jampol, Lee M.
    Aiello, Lloyd Paul
    Antoszyk, Andrew N.
    Arnold-Bush, Bambi
    Baker, Carl W.
    Bressler, Neil M.
    Browning, David J.
    Elman, Michael J.
    Ferris, Frederick L.
    Friedman, Scott M.
    Melia, Michele
    Pieramici, Dante J.
    Sun, Jennifer K.
    Beck, Roy W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (13): : 1193 - 1203
  • [4] Aflibercept monotherapy or bevacizumab first for diabetic macular edema
    Hostovsky, Avner
    Moroz, Iris
    Katz, Gabriel
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (SUPPL 2) : S260 - S264
  • [5] Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
    Jhaveri, Chirag D.
    Glassman, Adam R.
    Ferris, Frederick L., III
    Liu, Danni
    Maguire, Maureen G.
    Allen, John B.
    Baker, Carl W.
    Browning, David
    Cunningham, Matthew A.
    Friedman, Scott M.
    Jampol, Lee M.
    Marcus, Dennis M.
    Martin, Daniel F.
    Preston, Carin M.
    Stockdale, Cynthia R.
    Sun, Jennifer K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (08): : 692 - 703
  • [6] Aflibercept therapy for diabetic macular edema resistant to ranibizumab and bevacizumab
    Karth, Peter
    Moshfeghi, Darius M.
    Leng, Theodore
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [7] EFFECT OF INTRAVITREAL TRIAMCINOLONE IN DIABETIC MACULAR EDEMA UNRESPONSIVE TO INTRAVITREAL BEVACIZUMAB
    Jeon, Sohee
    Lee, Won Ki
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (08): : 1606 - 1611
  • [8] Aflibercept Monotherapy versus Bevacizumab-First for Diabetic Macular Edema
    Patel, Nimesh A.
    Al-Khersan, Hasenin
    Yannuzzi, Nicolas A.
    Lin, James
    Smiddy, William E.
    OPHTHALMOLOGY RETINA, 2023, 7 (05): : 413 - 419
  • [9] Comparative Effectiveness Trial of Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
    Sun, Jennifer K.
    DIABETES, 2015, 64 : A76 - A77
  • [10] Aflibercept in diabetic Macular Edema
    不详
    OPHTHALMOLOGE, 2015, 112 (04): : 311 - 311
12345